JOINDER AND AMENDMENT NO. 1 REGARDING CREDIT AGREEMENT dated as of September 26, 2011 among SAGENT PHARMACEUTICALS and SAGENT PHARMACEUTICALS, INC. each as Borrower and collectively as Borrowers and MIDCAP FUNDING III, LLC, as Agent and as a Lender...Regarding Credit Agreement • September 30th, 2011 • Sagent Pharmaceuticals, Inc. • Pharmaceutical preparations
This JOINDER AND AMENDMENT NO. 1 REGARDING CREDIT AGREEMENT (this “Agreement”) dated as of September 26, 2011 is by and among SAGENT PHARMACEUTICALS, a Wyoming corporation (“Existing Borrower”), SAGENT PHARMACEUTICALS, INC., a Delaware corporation (“New Borrower”; and together with Existing Borrower, sometimes referred to individually, each a “Borrower” and collectively as the “Borrowers”), MIDCAP FUNDING III, LLC, a Delaware limited liability company (“MCF”) as Agent (in such capacity, “Agent”) and as a Lender, and SILICON VALLEY BANK, a California corporation (“SVB”), as a Lender (collectively, with MCF, in its capacity as a Lender, “Lenders”).
